Plain-English translation of NCT06964620 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Diabetes Mellitus, Type 2 research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing , a herbal medication made from mulberry leaf, bitter melon, kudzu root, Chinese yam, and cassia seed, to see if it can help lower blood sugar in people with prediabetes or early-stage type 2 diabetes. Researchers believe the ingredients in this medication may help your body control blood glucose and improve how your body uses insulin. The study will compare people who take the medication with those who take a placebo (a pill with no active ingredient) to see which group has better blood sugar control.
Many people develop prediabetes or mild type 2 diabetes, and early treatment is important to prevent serious complications like heart disease. This medication offers a plant-based approach that may help control blood sugar without the side effects of some prescription drugs, but we need to prove it actually works.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be randomly assigned to take either or a placebo (an identical-looking pill with no active ingredient), plus any conventional treatment your doctor recommends. You will take one tablet twice daily for 16 weeks and have your blood sugar levels checked regularly through blood tests. The research team will monitor you closely for safety and measure how well the medication works by checking your blood glucose and other markers.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China